Expression of RPL29 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL29 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1332.55

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1712.5

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	4099.6
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	3868.5
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	3295.9
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	3222.8
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	3028.2
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2884.7
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	2869.7
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2819.2
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	2797.4
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2772.2
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2747.4
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	2643.9
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	2623.6
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2583.5
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	2554.3
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	2519.1
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2480.6
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	2446.4
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2396.4
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2330.0
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	2291.1
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	2281.4
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	2264.6
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	2256.7
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	2225.4
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	2198.9
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	2170.0
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	2127.0
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2112.5
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	2104.6
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2093.6
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	2088.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	2023.7
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	2009.4
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1915.8
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	1911.9
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1911.4
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	1905.5
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	1892.3
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1883.4
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	1873.0
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	1872.3
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	1859.8
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	1858.8
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1827.6
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1802.0
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	1795.7
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	1785.5
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	1777.4
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	1776.6
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1762.1
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	1755.8
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1748.2
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1742.2
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1727.7
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	1718.7
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	1714.4
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1708.2
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	1706.3
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1704.7
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	1693.8
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	1674.6
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	1674.5
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	1670.9
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1653.7
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1639.0
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1635.8
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1631.5
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	1626.7
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1588.0
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1573.6
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1572.3
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1564.1
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1522.8
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1521.5
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1516.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1515.3
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1512.3
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1508.8
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1494.8
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	1494.7
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1479.0
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	1477.6
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1476.6
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1474.1
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1473.9
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1456.5
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1437.3
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1420.2
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1401.1
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1397.7
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1387.3
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1385.0
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1380.5
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1380.0
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1377.0
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1364.2
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1362.9
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1353.6
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1342.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1340.6
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1332.6
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1329.4
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1327.5
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1316.5
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	1298.8
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1295.4
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1294.2
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1285.2
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1278.9
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1253.1
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1252.2
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1247.6
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1246.5
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1232.7
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1207.9
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1201.3
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1200.1
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1196.2
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1193.8
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1193.2
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1190.0
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1188.3
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1173.8
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1168.8
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1154.9
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1153.7
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1144.9
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1137.4
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1112.9
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	1110.4
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1110.1
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1061.5
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1004.2
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1003.4
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	970.5
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	900.5
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	857.8
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	802.6
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	720.9
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	693.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL29 is potential prognostic, high expression is favorable in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 214.24

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

363.3

Number of samples

Samples

Sample	Description	pTPM
AK139	N, NA, stage:NA, dead, 270 days	726.5
AK098	N, NA, stage:NA, dead, 660 days	686.4
AK142	N, NA, stage:NA, alive, 90 days	667.4
AK066	N, NA, stage:NA, alive, 960 days	663.8
AK068	N, NA, stage:NA, alive, 360 days	632.9
AK074	N, NA, stage:NA, alive, 300 days	625.6
AK178	N, NA, stage:NA, dead, 240 days	593.4
AK051	N, NA, stage:NA, dead, 360 days	581.4
AK055	N, NA, stage:NA, dead, 240 days	576.6
AK165	N, NA, stage:NA, alive, 360 days	563.3
AK236	N, NA, stage:NA, dead, 360 days	555.0
AK183	N, NA, stage:NA, alive, 360 days	533.1
AK185	N, NA, stage:NA, alive, 330 days	528.1
AK199	N, NA, stage:NA, alive, 1860 days	528.0
AK072	N, NA, stage:NA, dead, 150 days	527.4
AK188	N, NA, stage:NA, alive, 420 days	487.0
AK043	N, NA, stage:NA, alive, 660 days	486.3
AK049	N, NA, stage:NA, dead, 180 days	480.6
AK071	N, NA, stage:NA, dead, 540 days	478.2
AK053	N, NA, stage:NA, dead, 300 days	457.7
AK088	N, NA, stage:NA, dead, 360 days	451.3
AK149	N, NA, stage:NA, dead, 420 days	397.6
AK195	N, NA, stage:NA, dead, 390 days	392.0
AK213	N, NA, stage:NA, alive, 2010 days	384.0
AK041	N, NA, stage:NA, alive, 810 days	367.8
AK216	N, NA, stage:NA, dead, 360 days	367.4
AK100	N, NA, stage:NA, alive, 960 days	358.9
AK153	N, NA, stage:NA, dead, 240 days	341.1
AK076	N, NA, stage:NA, alive, 660 days	336.4
AK089	N, NA, stage:NA, dead, 330 days	321.8
AK173	N, NA, stage:NA, dead, 180 days	320.4
AK231	N, NA, stage:NA, dead, 240 days	319.3
AK167	N, NA, stage:NA, dead, 180 days	318.5
AK124	N, NA, stage:NA, alive, 1920 days	301.8
AK227	N, NA, stage:NA, alive, 300 days	293.4
AK002	N, NA, stage:NA, dead, 570 days	290.9
AK158	N, NA, stage:NA, dead, 360 days	282.4
AK003	N, NA, stage:NA, dead, 600 days	281.0
AK015	N, NA, stage:NA, alive, 720 days	269.0
AK133	N, NA, stage:NA, dead, 360 days	260.5
AK091	N, NA, stage:NA, dead, 210 days	260.5
AK103	N, NA, stage:NA, alive, 1320 days	255.8
AK085	N, NA, stage:NA, alive, 660 days	253.8
AK030	N, NA, stage:NA, dead, 120 days	240.3
AK102	N, NA, stage:NA, alive, 1740 days	224.6
AK134	N, NA, stage:NA, dead, 360 days	215.4
AK156	N, NA, stage:NA, dead, 330 days	213.1
AK123	N, NA, stage:NA, dead, 180 days	162.5
AK079	N, NA, stage:NA, dead, 210 days	155.2
AK205	N, NA, stage:NA, dead, 120 days	150.2
AK035	N, NA, stage:NA, dead, 210 days	147.5
AK218	N, NA, stage:NA, dead, 180 days	133.4
AK117	N, NA, stage:NA, dead, 210 days	126.2
AK005	N, NA, stage:NA, dead, 240 days	109.0
AK081	N, NA, stage:NA, dead, 180 days	107.8
AK099	N, NA, stage:NA, dead, 420 days	104.6
AK226	N, NA, stage:NA, dead, 360 days	103.6
AK006	N, NA, stage:NA, dead, 360 days	79.3
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0182580003	Tumor	1.6
CPT0208980003	Tumor	1.4
CPT0225760003	Tumor	1.3
CPT0218330004	Tumor	1.2
CPT0127480003	Tumor	1.1
CPT0218830004	Tumor	1.1
CPT0224390004	Tumor	1.0
CPT0228220003	Tumor	1.0
CPT0190360004	Tumor	1.0
CPT0219080004	Tumor	0.9
CPT0225730003	Tumor	0.9
CPT0168380003	Tumor	0.8
CPT0224540004	Tumor	0.8
CPT0216920008	Tumor	0.8
CPT0206560003	Tumor	0.7
CPT0125510003	Tumor	0.7
CPT0217710008	Tumor	0.6
CPT0189750004	Tumor	0.6
CPT0171580008	Tumor	0.5
CPT0218690004	Tumor	0.4
CPT0217100003	Tumor	0.4
CPT0089150003	Tumor	0.4
CPT0168080003	Tumor	0.4
CPT0079790003	Tumor	0.3
CPT0093510003	Tumor	0.3
CPT0162020003	Tumor	0.2
CPT0224330003	Tumor	0.2
CPT0206880003	Tumor	0.2
CPT0206000004	Tumor	0.2
CPT0127420003	Tumor	0.2
CPT0161730003	Tumor	0.1
CPT0207090003	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0125570003	Tumor	0.1
CPT0168830003	Tumor	0.1
CPT0224600003	Tumor	0.1
CPT0206230003	Tumor	0.0
CPT0093450003	Tumor	0.0
CPT0205450004	Tumor	0.0
CPT0093590003	Tumor	-0.1
CPT0217880003	Tumor	-0.1
CPT0168590003	Tumor	-0.1
CPT0205670004	Tumor	-0.1
CPT0189570004	Tumor	-0.1
CPT0002410011	Tumor	-0.1
CPT0093360003	Tumor	-0.1
CPT0217430008	Tumor	-0.1
CPT0205570003	Tumor	-0.1
CPT0217060003	Tumor	-0.1
CPT0162100003	Tumor	-0.1
CPT0071100003	Tumor	-0.2
CPT0182550003	Tumor	-0.2
CPT0168270003	Tumor	-0.2
CPT0206670004	Tumor	-0.2
CPT0167860004	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0064650003	Tumor	-0.2
CPT0182500003	Tumor	-0.2
CPT0087950003	Tumor	-0.2
CPT0168720003	Tumor	-0.2
CPT0186100003	Tumor	-0.2
CPT0168480003	Tumor	-0.2
CPT0189650004	Tumor	-0.2
CPT0078580003	Tumor	-0.3
CPT0064890003	Tumor	-0.3
CPT0093550003	Tumor	-0.3
CPT0206450003	Tumor	-0.3
CPT0206110003	Tumor	-0.3
CPT0206780003	Tumor	-0.3
CPT0206330003	Tumor	-0.3
CPT0205890003	Tumor	-0.3
CPT0205780003	Tumor	-0.3
CPT0123530003	Tumor	-0.4
CPT0218960004	Tumor	-0.4
CPT0167530003	Tumor	-0.4
CPT0175060003	Tumor	-0.4
CPT0207030003	Tumor	-0.4
CPT0201710003	Tumor	-0.4
CPT0189850004	Tumor	-0.4
CPT0217190003	Tumor	-0.4
CPT0196850003	Tumor	-0.5
CPT0125220003	Tumor	-0.5
CPT0104220003	Tumor	-0.5
CPT0217000004	Tumor	-0.5
CPT0167750004	Tumor	-0.5
CPT0209440003	Tumor	-0.6
CPT0221180003	Tumor	-0.6
CPT0190240004	Tumor	-0.6
CPT0167970003	Tumor	-0.6
CPT0087730003	Tumor	-0.7
CPT0218670003	Tumor	-0.8
CPT0087570003	Tumor	-0.8
CPT0204340003	Normal	-0.8
CPT0087680003	Tumor	-0.9
CPT0189250003	Tumor	-0.9
CPT0092440003	Tumor	-0.9
CPT0189460003	Tumor	-0.9
CPT0204380003	Normal	-0.9
CPT0218770003	Tumor	-1.0
CPT0204370003	Normal	-1.0
CPT0204400003	Normal	-1.1
CPT0104330003	Tumor	-1.1
CPT0199770003	Tumor	-1.1
CPT0204350003	Normal	-1.1
CPT0204360003	Normal	-1.1
CPT0204410003	Normal	-1.2
CPT0162140003	Tumor	-1.3
CPT0204390003	Normal	-1.5
CPT0204420003	Normal	-1.6
CPT0204330003	Normal	-1.7
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA069064
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade
Glioma, malignant, NOS Glioma, malignant, High grade